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1. Introduction
Long-term intracellular homeostasis maintains the
calcium concentration in muscle cells below micro-
molar by means of the cytoplasmic membrane ma-
chinery, the first barrier against extracellular Ca2q. A
large number of cellular functions, however, are gov-
erned by Ca2q, which acts as second messenger. This
is the case for the contraction of fast skeletal muscles
which is governed by Ca2q spikes, i.e. transient
increases in Ca2q concentration. In these cells, the
Ca2q ions migrate from the sarcoplasmic reticulum
 .SR , an intracellular organelle, to the contractile
system and conversely, from the contractile system to
the SR lumen. SR is a Ca2q reservoir which has two
functions in imposing fast changes in intracellular
Ca2q concentration: accumulation of calcium drawn
from the intracellular medium to induce muscle re-
laxation and calcium release to promote muscle con-
traction. Ca2q release occurs through channels
 . 2qryanodine receptor , whereas Ca uptake occurs
through an active pump, the Ca2q-ATPase.
This Ca2q-ATPase is easy to prepare in its native
orientation in tight vesicles i.e. right-side-out thus
preserving the physiological function of calcium ac-
.cumulation and can be stored frozen in 0.3 M su-
w xcrose 1 . It was discovered simultaneously in 1961
w x w xby Ebashi 2 and Hasselbach and Makinose 3 . One
w xyear later Hasselbach and Makinose wrote 4 : ‘‘1.
The unknown substance mentioned becomes a carrier
by phosphorylation on the outer surface of the gran-
ules which increases greatly its affinity for calcium.
2. The calcium complex of the phosphorylated carrier
diffuses to the inner surface of the membrane of the
granule. There the phosphate group is split off from
the carrier whereby the calcium affinity of the carrier
is strongly diminished. Thus, the bound calcium is
liberated in spite of the comparatively high concen-
tration of calcium inside.’’
The stage for future work on SR vesicles was
therefore set, even if today we consider that the
Ca2q-ATPase belongs to the P-class of the ion motive
ATPases, i.e. is covalently phosphorylated by ATP
during its pumping cycle.
In 1973, Makinose proposed a model for Ca2q
transport in which the Ca2q-ATPase can adopt two
conformations during the calcium transport cycle.
This model, strongly substantiated by de Meis and
Scheme 1.
w xcoworkers 5 , is represented in its simplest form in
Scheme 1. This scheme should be taken as opera-
tional, and describes the minimum number of events
necessary for the transport of two Ca2q ions through
the SR membrane and against its concentration gradi-
ent at the expense of the hydrolysis of one ATP
molecule.
According to Scheme 1, in the E form the two
Ca2q transport sites have a high affinity for Ca2q and
an outward cytosolic orientation. Therefore, E is able
to capture Ca2q at a low concentration in the cytoso-
lic medium and, after Ca2q binding and in the pres-
ence of Mg2q, Ca E is phosphorylated by ATP into2
Ca E-P. In the Ca E-P complex, the Ca2q ions are2 2
occluded, i.e. they cannot be rapidly exchanged either
from the outside or from the inside of the SR vesicles
w x6,7 . This phosphoenzyme is unstable, and under-
goes a conformational change leading to Ca2q disso-
ciation toward the lumen. The Ca2q-deprived phos-
phoenzyme E-P has transport sites with low affinity
for Ca2q and inward lumenal orientation. Therefore
in step 3, that is during the Ca E-PlE-P transition,2
the calcium is physically released into the SR vesicle
lumen. Finally, in step 4, the E-P phosphoenzyme is
hydrolyzed and the enzyme is thus ready for the next
cycle. Scheme 1 predicts that in symmetry with the
Ca E-PlE-P transition, the ElCa E step corre-2 2
sponds to a change in affinity and a reorientation of
the transport sites. We will come back to this point
later.
An important feature of the Ca2q-ATPase cycle is
w xits total reversibility 8,9 , which has greatly facili-
tated the study of the transport cycle. In practical
terms two situations can be distinguished. When
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placed in a Ca2q-deprived medium, SR ˝esicles pre-
˝iously loaded with calcium can synthesize ATP
 .from ADP and inorganic phosphate P at the ex-i
pense of the efflux of two Ca2q per ATP synthesized.
ATP synthesis lasts as long as the Ca2q gradient and
the ADP and P pool allow the reverse cycle to work.i
In the absence of a Ca2q gradient, leaky ˝esicles
can synthesize ATP by describing, step by step, the
ATPase cycle in the reverse direction. Here, synthesis
starts by spontaneous phosphorylation of the protein
by P in the presence of Mg2q and absence of Ca2qi
w x10,11 , i.e. step 4 which leads to the formation of
E-P. In the next step, millimolar Ca2q and ADP are
added together. Since the vesicles are leaky, the Ca2q
ions bind to the internal Ca2q sites, thus inducing the
formation of the Ca E-P species, which in turn binds2
ADP and transfers its bound phosphate to ADP to
synthesize one molecule of ATP.
It is interesting to note that Scheme 1 has been
generalized to the whole class of the P-type ATPases
and therefore the following discussion may be trans-
posed to all transport ATPases taking into account
the specificity of each system for the transported
 . q q q q qion s : Na , K -ATPase, H , K -ATPase, H -
ATPase, etc. Any progress in the understanding of
any of these ATPase mechanisms is useful for the
study of all other P-type ATPases.
2. Ca2H-ATPase membrane environment
After a few differential centrifugations, 400 g of
rabbit skeletal muscle yield 400 mg of Ca2q-ATPase,
embedded in the native lipid environment. An incuba-
tion step in 0.5 M sucrose during the preparation is
designed to remove the heavy SR fraction, i.e. the
fraction supposed to contain the Ca2q-release chan-
nel. The fraction collected after this step, i.e. the light
SR fraction, comprises 100-nm diameter sealed vesi-
cles which retain the physiological orientation, i.e.
they actively pump Ca2q. In these vesicles, 80% of
the protein is Ca2q-ATPase and the remaining 20% is
essentially calsequestrin and M55-glycoprotein. The
latter proteins are thought to be extrinsic and located
in the vesicle lumen. Calsequestrin, which binds 40
Ca2q ions per monomer, acts as a Ca2q chelator
which lowers the lumenal concentration of free Ca2q
and therefore facilitates accumulation of large
2q w xamounts of Ca ions 12 .
2.1. LipidrCa2q-ATPase interactions
SR vesicles contain 0.6 mg lipid per mg protein
and this represents 80–100 mol phospholipids per
2q  w x.mol Ca -ATPase for a review see 13 . Of these
lipids, phosphatidylcholine accounts for 70% and
phosphatidylethanolamine for 15–20%. Phos-
phatidylinositol and cholesterol are also present in
measurable amounts. The fatty acid composition of
the lipids is mainly palmitate, oleate and linoleate.
The distribution of the lipids in the SR vesicle mem-
brane is asymmetric. The inner leaflet contains more
phospholipids and concentrates phosphatidylinositol
and to a lesser extent phosphatidylethanolamine. In
contrast, phosphatidylcholine is mainly present in the
outer leaflet.
The Ca2q-ATPase activity depends on the pres-
ence and the physical state of the lipids. When phos-
pholipids are in the gel phase, Ca2q-ATPase activity
w xis low 14 . Maximal activity requires the lipids to be
in the fluid state. Phospholipid extraction by deter-
gents does not affect ATPase activity as long as a
minimum of 30 mol phospholipids is left per mol
2q w x 2qCa -ATPase 15 . Below this ratio, Ca -ATPase
begins to be reversibly inhibited. During delipidation,
the composition of the lipid phase of the membrane
remains unchanged. It has been proposed that the
hydrophobic part of the Ca2q-ATPase is surrounded
by a lipidic annulus composed of 20 to 30 phospho-
w xlipids 15,16 . This assumption is in agreement with
the ESR spectra of spin-labeled phospholipids which
show the existence of mobile and immobile popula-
w xtions of lipids 15,16 . However, it was shown by
NMR that the rate of exchange of boundary lipids
with bulk lipids is several orders of magnitude faster
2q w xthan the turnover of the Ca -ATPase 17 . This
finding raises the question of the existence and the
significance of the boundary lipids. This is still an
open question as shown by recent results. For in-
stance, digestion of the membrane phospholipids by
phospholipases of broad specificity promotes contin-
2q w xuous decrease in Ca -ATPase activity 18 , which
does not support the lipid ‘annulus’ assumption,
whereas an infrared spectroscopic study describes a
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‘hard-to-exchange’ phospholipid population sur-
2q w xrounding the Ca -ATPase 19 .
2.2. Is the membranous Ca2q-ATPase a polymer?
Early electron microscopy studies of SR vesicles
indicated a way to determine the degree of poly-
merization of the Ca2q-ATPase in its membranous
form. Freeze-fracture replica revealed 5730 parti-
clesrmm2, whereas 21 000 particlesrmm2 were visi-
ble on the membrane surface of etched specimens
w x20 . It was tempting to explain this difference by
supposing that etching revealed monomers of Ca2q-
ATPase whereas freeze-fracture replica revealed
trimers or tetramers. Whatever the limits of electron
microscopy, the packing of the Ca2q-ATPase in its
membrane may be as high as 30 000 monomersrmm2
w x21 and thus, in such a crowded membrane, it is
difficult to differentiate non-specific from specific
interactions. One way to overcome this difficulty is to
use detergents to solubilize the SR vesicles, assuming
that solubilization does not markedly change
protein-protein interactions. Since the pioneering
w xwork of Tanford and coworkers 22 , systematic study
of the solubilization of the SR membrane by the
numerous commercially available detergents has led
to major advances, mainly in preserving ATPase
w xactivity 23 . This improvement in solubilizing the
Ca2q-ATPase led to progress in fields as different as
2q w xCa -ATPase purification 24,25 , three-dimensional
w x 2qcrystallization 26 , reconstitution of the Ca -ATPase
w xin synthetic proteoliposomes 27,28 and functional
study of the monomeric form of the Ca2q-ATPase
w x29 .
Despite the numerous techniques used to gain
more information about the protein-protein interac-
tion in the SR membrane, the question of oligomer-
ization of the Ca2q-ATPase in the SR membrane is
unsolved. Clearly a monomer can describe the whole
ATPase cycle including changes in affinity for Ca2q,
w xthus mimicking the transport steps 30,31 , but the
assumption of an oligomeric structure has been put
forward to explain particular features of ATPase ac-
w xtivity, such as activation by excess ATP 32 . In
addition, according to Froehlich, Thomas and
coworkers, the oligomeric structure of the Ca2q-
ATPase in the native SR vesicles is confirmed by
kinetic features of the transport cycle for references
w x.and recent discussion of this question see 33 .
3. Structure of the Ca2H-ATPase
The primary sequence of the Ca2q-ATPase was
established in 1985 by MacLennan and co-workers
w x34 after sequencing the encoding DNA. The protein
comprises a unique polypeptide of 994 amino acids
w xwhich, according to Daiho and Kanazawa 35 , is
likely to comprise 2–3 disulfide bonds, the reduction
of which leads to virtually total inhibition of the
2q lumenal Ca dissociation Ca E-PlE-P step 3 in2
. 2qScheme 1 . To date, the Ca -ATPase has not been
crystallized in an appropriate form for X-ray diffrac-
tion and there is a definite lack of experimental data
to confirm the various models which have been pro-
posed for the secondary and tertiary folding of the
protein. We will consider here the model proposed by
w x  .Green and Stokes 36 Fig. 1 which is the most
consensual and which has recently been substantiated
w xby Toyoshima et al. 37 . The latter authors have
constructed a three-dimensional representation of the
2q  .envelope of the Ca -ATPase Fig. 2 , starting from
cryo-electron microscopy data of tubular crystals in
native membrane. The images of these crystals diffract
˚at 14 A and give the general shape of the molecule
which has been interpreted by Toyoshima and
 .coworkers in terms of the 10 helices model Fig. 1 .
Two-dimensional crystals of Ca2q-ATPase were
w xdescribed in 1983 by Martonosi and coworkers 38
w x.and for a recent review see 39 who found that in
native SR membrane the Ca2q-ATPase can crystallize
in two different forms. In the absence of Ca2q, a
medium containing vanadate and Mg2q induces crys-
tallization of Ca2q-ATPase dimers as unit cell, thought
to represent the crystallization motif of E, the Ca2q-
deprived form. In the presence of Ca2q or lan-
thanides, the crystals have monomers as unit cell,
which are thought to represent the crystallization
motif of Ca E, the Ca2q-bound form. This work led2
to the first isodensity contour maps of SR membrane
crystals but, as the electron microscopy experiments
were conducted after negative staining, the major part
of the membrane domain was not revealed. The
cryo-electron microscopy experiments of Taylor et al.
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w x w x40 and Toyoshima et al. 37 on crystals embedded
in vitreous ice, and therefore unstained, enabled the
authors to give a more precise evaluation of the
dimensions and mass distribution of the whole Ca2q-
ATPase. This is shown in Fig. 2 from Toyoshima et
w xal. 37 , which gives the general shape of the molecule
˚with a total height of 120 A and 70% of the mass in
the cytoplasmic domain, 25% in the membrane and
5% in the lumen. The intramembranous details in
Fig. 2 are a tentative fit of the general shape of the
Ca2q-ATPase to the 10-helix model shown in Fig. 1.
In this model, the membrane part of the Ca2q-ATPase
is formed by 10 helices joined by 5 lumenal short
loops and 4 cytoplasmic loops. The cytoplasmic part
of the molecule is linked to the 10 membrane helices
by a ‘stalk’ which maintains the hydrophilic globule
in the external bulk where are also located the N- and
C-terminus peptides formed of 60 and 7 amino acids,
respectively. Before briefly reviewing the main spe-
cific sites of the Ca2q-ATPase, it should be borne in
mind that the catalytic site which comprises the ATP
binding site and the phosphorylation site is located in
Fig. 2. Ca2q-ATPase shape, as proposed by Toyoshima et al.
w x37 .
2q w xFig. 1. Ca -ATPase tertiary structure prediction, as proposed by Green and Stokes 36 .
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the cytoplasmic part of the molecule whereas the
transport sites, i.e. the Ca2q-binding sites, are thought
to be buried in the membrane. Therefore, two regions
˚located 40 A away interact at each step of the
transport cycle, to translocate two Ca2q ions.
3.1. Calcium-binding sites
In a study of a Ca2q-ATPase modified with DCCD,
Pick and Racker proposed in 1979 that the Ca2q-bi-
nding sites were hydrophobic, although containing
w xcarboxyl groups 41 . Since then, numerous chemical
studies using DCCD or analogs have confirmed this
early hypothesis for recent work and references see
w x.42 . More precision has been gained from site-di-
rected mutagenesis in the M4, M5 and M6 membrane
 . 309regions Fig. 1 . It has been shown that Glu ,
Glu771, Asn796, Thr799, and Asp800 are essential for
Ca2q transport, Ca2q-dependent phosphorylation by
2q w xATP and Ca occlusion 43–45 . Since then, inves-
tigations of dozens of mutations have shown that
both or only one of the two Ca2q-binding sites can be
w x 309 796hit. According to Andersen 46 , Glu and Asn
are associated with one site, Glu771 and Thr799 are
associated with the other and Asp800 is associated
with both. This suggests that the two sites are distin-
guishable. The possibility that the two Ca2q ions can
be superimposed in a channel has been suggested
2q w xfrom studies of the Ca -binding reaction 47 and it
has since been suggested that M4, M5, M6 and M8
 .form such a channel across the membrane see Fig. 1
w x 309 77136,43,48 . The spatial arrangement of Glu , Glu ,
Asn796, Thr799, and Asp800 in the membrane is still
w xdiscussed in the literature 37,39,46,48–50 . The exis-
tence of such a channel will be discussed below in
the section devoted to the Ca2q translocation mecha-
nism.
3.2. ATP-binding site
Compared to the Ca2q-binding sites, the ATP-bi-
nding site is more difficult to delineate. It has mainly
been studied by chemical modifications, labeling with
ATP analogs inducing covalent binding and site-di-
rected mutagenesis.
The Ca2q-ATPase possesses 24 Cys which react
with SH reagents. Of these, nine are protected by
ATP. They may be involved in the ATP-binding site
and ATP-induced conformational changes for recent
w x.studies see 33,51 . A very specific chemical modifi-
cation has been achieved by stoichiometric labeling
of a Lys with FITC. Knowledge of the primary
sequence of the Ca2q-ATPase shows this to be Lys515
w x52–55 . This chemical modification proved remark-
able in several ways. In particular, the method was
derived from similar labeling of the Naq, Kq-ATPase
 w x.see references in 53 and seems to be generally
applicable to labeling of the ATP-binding site of
 w x qP-type ion motive ATPases see 56 for the H ,
q w x q .K -ATPase and 57 for the yeast H -ATPase .
FITC-labeling of Ca2q-ATPase inhibits ATP binding
but does not change the interaction with smaller
substrates such as acetylphosphate and does not in-
hibit the reverse phosphorylation by P . An FITC-i
modified Ca2q-ATPase can therefore describe the
whole cycle using acetylphosphate as substrate, with
a fluorescent chromophore attached to Lys515, which
is in the vicinity of the ATP-binding site.
A second remarkable chemical modification is in-
tramolecular crosslinking by glutaraldehyde under
mild conditions. This reaction, which crosslinks
Lys492 and Arg678, is inhibited by nucleotide binding
or by formation of E-P, the ADP-insensitive phos-
w xphoenzyme 58 . This second modification of the
Ca2q-ATPase, which results in substantial inhibition
of ATPase activity, also proved to be an interesting
tool for study of the coupling between ATP hydroly-
2q w x 2qsis and Ca transport 59 . The cross-linked Ca -
ATPase is phosphorylatable by acetylphosphate, but
once Ca2q is occluded, it is released in the cytoplasm
instead of the lumen.
Azido derivatives of ATP are able to bind cova-
lently to the catalytic site after irradiation, e.g. TNP-
492 w x8-azido-AMP or -ATP labels Lys 60 and 8-azido-
532 533 w xADP labels Thr and Thr 61 . Pyridoxal deriva-
tives of ATP also react with Ca2q-ATPase, labeling
Lys684 in the presence of Ca2q and Lys492 and Lys684
2q w xin the absence of Ca 62 .
Site-directed mutagenesis of highly conserved re-
gions among the family of cation transporting AT-
 519 629.Pases KGAPE and RDAGIRVIMITGDNK
has shown that only Gly 626 and Asp627 are essential
w xfor phosphoenzyme formation 63 . An interesting
conclusion of this work was that most of the amino
acids of these regions are not essential for nucleotide
binding. In particular, mutation of Lys515 reduced
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Ca2q transport without affecting phosphoenzyme for-
mation.
The above difficulties in delineating the ATP-bind-
ing site could indicate that it is composed of several
peptides scattered through the primary sequence and
has no crucial amino acid whose modification greatly
affects the ATP-binding properties of the Ca2q-
ATPase. Such tertiary folding of the ATP site has
w xbeen proposed by Taylor and Green 64 and is
topologically equivalent to that of adenylate kinase.
3.3. Phosphorylation site
The existence of a phosphoenzyme was suggested
w xby Hasselbach and Makinose in 1962 4 . The phos-
phoprotein was isolated and its chemical properties
w xwere described by Makinose in 1969 65 . The phos-
phorylated amino acid was characterized as an as-
w xpartyl residue by Degani and Boyer in 1973 66 and
a peptide containing the phosphorylation site was
w xsequenced by Allen and Green in 1976 67 . The full
primary sequence has enabled the aspartyl residue to
351 w xbe identified as Asp 55 .
Site-directed mutagenesis has since shown that
Asp351 is an absolute requirement for the Ca2q-
ATPase but that conservative mutations of Cys349,
Lys352 and Thr 353 do not impair phosphorylation
w x 2q63 . The Ca -ATPase can therefore accommodate
minor changes in the immediate environment of the
phosphorylation site.
4. Function
4.1. Thapsigargin
Thapsigargin is a specific inhibitor which allows
detection of sarco- and endoplasmic Ca2q-ATPases
 . w xSERCA 68 . Thapsigargin binds to the sarco-
plasmic Ca2q-ATPase with a one-to-one stoichiom-
etry and a sub-nanomolar affinity on the third trans-
w x 2qmembrane segment M3 69 . In the presence of Ca
and ATP, during turnover, thapsigargin slowly in-
hibits Ca2q-ATPase activity and Ca2q transport by
binding to E, the Ca2q-deprived intermediate, at each
cycle. When incubated with thapsigargin in the ab-
sence of Ca2q, the enzyme is trapped in a dead-end
complex leading to total inactivation.
4.2. Stoichiometries
In the absence of calcium, leaky SR vesicles dis-
play low ATPase activity of approximately 0.03 mmol
of ATP hydrolyzed per min and per mg of total
 2qprotein pH 7, 208C, 100 mM KCl, 3 mM Mg , 1
.mM ATP are considered as standard conditions .
Micromolar Ca2q concentrations activate this basal
ATPase activity about 100-fold. Ca2q ions therefore
trigger their own transport. In tight vesicles, the
activity is high until the Ca2q concentration in the
vesicles reaches a few millimolar. This internal Ca2q
concentration inhibits Ca2q release and the Ca2q-
pump only compensates the Ca2q leaking out from
the vesicles. Vesicles from the light fraction accumu-
late up to 80 nmol of Ca2q per mg of total protein.
More calcium can be stored in the vesicle lumen in
the presence of a chelating anion such as oxalate or Pi
by promoting Ca.P or Ca.oxalate complexes which,i
due to high lumenal Ca2q, precipitate inside the
vesicles. The drop in lumenal free Ca2q concentra-
tion allows accumulation of several mmol of Ca2q
w xper mg of total protein 70 .
In its membranous form, the enzyme binds about
10 nmol Ca2q per mg protein which corresponds to
twice the maximum stoichiometry of phosphorylation
by ATP. Taking 80% of the total protein as a mini-
mum value for ATPase content in a vesicular prepa-
w xration of SR 24 , the above stoichiometry of phos-
phorylation indicates that approximately 50% of
vesicular ATPases are phosphorylatable. This could
be explained by half-of-the-sites reactivity because of
Ca2q-ATPaserCa2q-ATPase interaction if Ca2q-
 .ATPase were a dimer see above , or by 50% denatu-
ration of Ca2q-ATPase during SR preparation. How-
ever, after purification on an anion-exchange column,
the phosphorylation stoichiometry increased to 7.3
w xnmolrmg 25 , a value close to that expected if all
ATPases are phosphorylated. It should be borne in
mind that purification of the Ca2q-ATPase necessi-
tates solubilization of the vesicles and therefore loss
of the native organization of the protein in the SR.
Because monomeric ATPase has been shown to fol-
w xlow the whole ATPase cycle 30,31 , we will con-
 .sider in the following that: i 50% of the ATPase is
 .active, ii the monomer is the functional unit in the
 .transport cycle, and iii one monomer has two high-
affinity transport sites accessible from the cytoplasm
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andror two low-affinity transport sites accessible
from the lumen and one catalytic site. We will dis-
cuss below the classical point of view that two Ca2q
sites change their orientation and accessibility during
w xtransport 5 and a recent proposal of two pairs of
Ca2q sites, one pair being accessible to Ca2q after
w xthe other 71,72 .
4.3. Counter-transport
Several millimolar Ca2q accumulates in the SR
lumen. This accumulation of four positive charges
per turnover must be counter-balanced to allow sev-
eral consecutive cycles to occur. It has been succes-
sively proposed that Mg2q andror Kq may be ex-
2q w x 2qchanged for Ca 73 , that the Ca -ATPase is
electrogenic and Ca2q uptake is balanced by Kq
q w x 2qefflux through a K channel 74 , that the Ca -
ATPase is an Hq pump generating an Hq gradient
2q w xwhich sustains Ca transport 75 , and finally that
q 2q w xH is exchanged for Ca 76 . The difficulty in
these studies is to analyze whether the counter-bal-
ancing charges are transported by the Ca2q-ATPase
itself or by diffusion across the vesicle membrane
which is permeable to Hq, or even via another trans-
porter. For instance, a Pi transporter has been found
in the native SR membrane and could mediate charge
w xcounter-balancing 77 .
The assumption that Hq is exchanged for Ca2q
was strongly substantiated when Yamaguchi and
Kanazawa showed that Hq ejection during Ca2q
uptake is due to a Ca2qrHq exchange mediated by
2q w xthe Ca -ATPase itself 78,79 . Nevertheless, because
of membrane permeability, no electrical potential dif-
ference or Hq gradient can be accurately measured in
native vesicles. Recently, Levy et al. succeeded in´
reconstituting the Ca2q-ATPase in proteoliposomes
of low ionic permeability and proposed that the
Ca2q-ATPase operates as an antiporter exchanging
q 2q w xthree H for two Ca 80 . The same reconstitution
protocol has also shown that this antiporter is electro-
w xgenic 81 .
We will now present separately the two main
aspects of Ca2q pumping, i.e. the molecular events
occurring during migration of Ca2q ions across the
ATPase and the associated steps of ATP utilization as
source of energy. This choice separates the vectorial
events from the chemical events, although these vec-
torial and chemical events are interlinked all along
w xthe cycle 82 .
4.4. Calcium migration across the ATPase
4.4.1. Equilibrium calcium binding
Cytoplasmic Ca2q ions bind to two high-affinity
sites per monomer of Ca2q-ATPase. These sites are
sensitive to the lipid environment as illustrated by
half-Ca2q binding stoichiometry when ATPase is
 .reconstituted in vesicles made of short- C or14:1
 . w xlong-chain C phosphatidylcholines 83 . ATPase24:1
can bind other divalent cations such as Sr 2q and
2q w xBa 84 , but transport has been characterized only
2q w x 2qfor Sr 84–86 . Mn has been shown to be a
2q w xweak inhibitor of Ca transport 76 and it is inter-
esting to note that the binding of lanthanides to
ATPase follows a complex process. Several groups
have reported that the sites of highest affinity for
2q w xlanthanides are not the Ca sites 87–89 .
At equilibrium, Ca2q binding to the two high-af-
w xfinity sites is cooperative 90 . The cooperativity is
sensitive to the lipid environment as it is abolished by
w xsolubilization with dodecylmaltoside 91 . The pH
affects the Ca2q-binding reaction: the half-saturation
concentration increases from 0.1 mM to 10 mM, and
the Hill coefficient from 1.3 to 2, when pH drops
w xfrom 8 to 6 92 . Positive cooperativity indicates that
the two Ca2q ions bind sequentially and it was shown
that Hq inhibits both Ca2q-binding steps. Forge et al.
proposed the Scheme 2 mechanism to explain this
2q w xinhibition of Ca binding 92 .
In Scheme 2, the cooperativity increases at acidic
pH because Hq inhibits the binding of the first Ca2q
more than it inhibits the binding of the second. At pH
6, the binding of two Ca2q ions induces the dissocia-
tion of three Hq. Additional evidence of the sequen-
tial character of the Ca2q-binding reaction has been
w xprovided by Fujimori and Jencks 93 who studied
Scheme 2.
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Sr 2q binding. Sr 2q binds to the ATPase with nega-
tive cooperativity and an intermediate species with
only one bound Sr 2q ion has been demonstrated.
Ca2q binding is inhibited by Mg2q, which is the
co-substrate for phosphorylation and is thought to
bind to the catalytic site. The inhibition by Mg2q in
Scheme 2 is explained by the fact that when the
transport sites are saturated with Ca2q, the affinity of
the catalytic site for Mg2q becomes low unless the
2q w xMg is complexed by ATP 94 . This has been
w x 2qdirectly shown by Ogumsu et al. 95 using Mn as
an Mg2q analogue. Therefore, following Forge et al.,
the Mg2q ion binds preferentially to species not
saturated with Ca2q and, in Scheme 2, impairs the
binding of the second Ca2q. This explanation is at
w xvariance with the results of Reinstein and Jencks 96
who measured an affinity of 1 mM for Mg2q in the
presence of Ca2q and with the results of Coan et al.
w x 2q97 who found that the protection by Mg against
EDC-labeling was greater in the presence of Ca2q,
whereas Ca2q does not exert any protection by itself.
These few results show that the Mg2q-binding mech-
anism is not yet clear cut and the co-existence of
several Mg2q-binding sites is still under debate.
4.4.2. Calcium binding, fluorescence and phosphory-
lability
After Ca2q binding the Ca2q-ATPase becomes
phosphorylatable by ATP. The Ca2q-binding step is
thus a switch in chemical reactivity and Scofano et al.
have shown that it is one of the rate-limiting steps of
w xthe cycle 98 . Phosphorylation by ATP is slow when
a Ca2q-deprived enzyme is phosphorylated by a mix-
ture of Ca2q and ATP but is fast when ATP is added
2q w x 2qto an enzyme incubated in Ca 98 . The Ca -bind-
ing step is thus thought to comprise a slow conforma-
 .tional change Scheme 3 . The first direct measure-
ment showing that Ca2q binding is slow was made
by Dupont and Leigh using the stopped flow tech-
nique and analysis of the kinetics of the intrinsic
ATPase fluorescence increase upon Ca2q binding
w x99 . Recently, Girardet and Dupont repeated the
stopped flow experiment and analyzed the circular
2q w xdichroism signal induced by Ca binding 100 .
Scheme 3.
They found rate constants very similar to those deter-
mined by fluorescence, confirming that the fluores-
cence signal is associated with an ATPase conforma-
tional change. In addition, parallel measurements of
fluorescence changes induced by Ca2q and phospho-
enzyme formation after sequential addition of Ca2q
and ATP show that the fluorescence changes and the
ability of ATPase to be phosphorylated appear at the
w xsame rate 101 .
4.4.3. Calcium binding and dissociation mechanisms
In 1980, Inesi et al. proposed that Ca2q binding
occurs as a two-step process, comprising fast binding
of a first Ca2q followed by a slow conformational
2q w xchange which allows binding of a second Ca 90 .
This proposal has been supported by several laborato-
w xries 101–103 . The existence of a fast phase depends
on experimental conditions: it is favored by the pres-
ence of Mg2q, by neutral or alkaline pH, and by low
w xtemperatures 102–104 . Recently, from studies of
the effect of Hq and Mg2q on both Ca2q-binding
kinetics and equilibrium, Forge et al. proposed that
the existence of one or two phases depends on the
various ATPase forms existing prior to Ca2q addition
w x 2q92,94 . Namely, in the absence of Ca , ATPase is
in various forms depending on both Hq and Mg2q
concentrations and the existence of a fast phase is
correlated with the existence of a deprotonated form
 .E in Scheme 2 . For instance, at pH 9, where all
ATPase is in E, Ca2q binding is monophasic and
fast. Conversely, at pH 6, where EH is predomi-3
nant, Ca2q binding is monophasic and slow because
it first necessitates slow deprotonation. At intermedi-
ate pH, the proportion of fast and slow phases de-
pends on the proportion of deprotonated and proto-
nated forms. Mg2q favors ATPase deprotonation and,
as a consequence, the existence of a fast phase. Such
a pH dependent equilibrium of the Ca2q-deprived
ATPase was proposed by Pick and Karlish for an
w xFITC-labeled ATPase 105 and by Wakabayashi et
w xal. for an NBD-labeled ATPase 106 . In addition,
HqrCa2q exchange during Ca2q binding was de-
scribed in the fundamental work of Yamaguchi and
w x w xKanazawa 78,79 . Forge et al. 92 took into account
the effect of Mg2q and proposed a two-route pH-de-
pendent mechanism.
Under conditions where the equilibrium Ca2q dis-
sociation constant is 10 mM pH 6, 208C, 5 mM
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Scheme 4.
2q. 2qMg , dissociation is slowed by 0.3 mM Ca
w x 2q101,107 . This is an indication for a Ca site of
higher affinity than the apparent equilibrium affinity.
The two Ca2q ions are known to be kinetically
distinguishable since Dupont showed that when the
ATPase is saturated by radioactive 45Ca2q, dissocia-
tion of half the 45Ca2q bound to the enzyme was
prevented by the presence of excess 40Ca2q in the
medium whereas, with EGTA, both 45Ca2q ions dis-
w xsociate rapidly 102 . This has been confirmed by
several authors under various experimental condi-
tions, different temperatures, pH, Mg2q concentra-
w xtions 47,94,108–110 . A simple possibility for two
sites being sequentially accessible from the cyto-
plasm is a narrow channel with a deep site and a
superficial site. In such a model, the sites are not
accessible simultaneously so that during the Ca2q-bi-
nding process the first ion that is bound to the
superficial site must move to the deep site to allow
the second ion to bind to the superficial site. As
exemplified in Scheme 4, the Ca2q bound to the
superficial site is exchangeable with the outer
medium, whereas the Ca2q bound to the deep site is
not. Thus, the more 40Ca2q in the medium, the
slower the dissociation of the deep 45Ca2q. In this
model, the superficial site affinity can be evaluated
by following the rate constant of the slow phase as a
40 2q w xfunction of Ca . Orlowski and Champeil 110
found that 3 mM 40Ca2q reduced this rate constant
by 50% at pH 6, 208C, 20 mM Mg2q where the
overall affinity for Ca2q is about 30 mM. Forge et al.
w x94 showed by similar measurements that the so-de-
fined affinity of the superficial site is pH-dependent
0.05 mM at pH 7 and 0.6 mM at pH 6, 208C, no
2q.Mg , confirming the existence of the EHCa species
in Scheme 2.
4.4.4. Calcium occlusion
Once the transport sites are saturated with Ca2q,
ATPase becomes phosphorylatable by ATP, the phos-
phorylation reaction occurs rapidly and is followed
w xby fast ADP dissociation 111,112 . Phosphorylation
2q w xinduces occlusion of the two bound Ca 6,7 . This
refers to a state from which Ca2q cannot dissociate
unless a slow conformational change occurs or re-
verse dephosphorylation is induced by ADP. Study of
the occluded state is difficult when using the natural
substrate MgATP because Ca E-P, the Ca2q-bound2
phosphoenzyme, is intrinsically unstable. Using
CrATP instead of MgATP, Vilsen and Andersen
w x113 were able to stabilize the intermediate species
containing occluded Ca2q, although ATPase is not
phosphorylated under these conditions.
Ca2q occlusion in the phosphorylated ATPase oc-
curs together with a change in the accessibility of the
Ca2q sites, which become inaccessible from the cyto-
w xplasmic side and accessible from the lumenal side 6 .
Once Ca2q is occluded in tight vesicles, Ca2q disso-
ciation by EGTA is not possible unless ADP is also
added. Addition of EGTA plus ADP induces rapid
dephosphorylation and Ca2q dissociation toward the
cytoplasmic side of the membrane. This shows that
the occluded Ca2q was still bound to ATPase prior to
dephosphorylation and was not yet dissociated inside
the vesicles. In contrast with tight vesicles, in leaky
vesicles, when the lumenal Ca2q sites become acces-
sible from the bulk, EGTA induces both Ca2q disso-
ciation toward the lumen and ATPase dephosphoryla-
tion. In leaky vesicles, an occluded state is character-
ized by a slow EGTA-induced dissociation and, as in
tight vesicles, a mixture of EGTA plus ADP induces
rapid dephosphorylation and Ca2q dissociation to-
w xward the cytoplasmic side of the membrane 114 .
4.4.5. Lumenal calcium sites
Once the calcium sites have become accessible
from the lumen, the affinity of Ca2q ions for the
ATPase should decrease to allow their dissociation
toward the SR lumen, which stores Ca2q. Bearing in
mind that a high lumenal Ca2q concentration impairs
Ca2q dissociation, the change in affinity of the Ca2q
sites is illustrated by the bell-shaped dependence of
the ATPase activity of leaky vesicles on Ca2q con-
w xcentration 115 . ATPase activity is stimulated in the
micromolar range and inhibited in the millimolar
range of Ca2q. Nevertheless, this inhibition by mil-
limolar Ca2q does not allow the direct determination
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of the lumenal sites’ affinity because with millimolar
Ca2q the CaATP complex concentration becomes
significant compared to that of the MgATP complex.
Thus, part of ATPase cycles slowly because it is
w xsupplemented by CaATP instead of MgATP 116 .
This second source of inhibition further increases
inhibition by Ca2q binding at the low-affinity sites.
Increasing Mg2q shifts the inhibition toward higher
Ca2q concentrations, probably by changing the
MgATP to CaATP ratio.
Theoretically, evaluation of the lumenal affinity
for Ca2q should be possible by measuring Ca2q
binding to E-P, the Ca2q-deprived phosphoenzyme
 . 2qstep 3 in Scheme 1 . In the SR lumen, bound Ca
cannot be distinguished from free Ca2q using tight
vesicles preloaded with Ca2q. The use of leaky vesi-
cles does not allow formation of a stable phosphoen-
zyme with bound Ca2q because the affinity of the
lumenal sites is lower than that of the cytoplasmic
sites. Therefore, addition of Ca2q to E-P induces
2q dephosphorylation and Ca binding to E steps 4
. w xand 1 in Scheme 1 117 .
However, it is possible to evaluate an apparent
affinity for lumenal Ca2q by studying how phospho-
 .rylation by P steps 4 and 3 and ATP synthesisi
 . 2qsteps 4 to 2 depend on lumenal Ca . Prager et al.
have measured the phosphorylation level from P ini
the presence of various lumenal Ca2q concentrations
and have estimated an apparent dissociation constant
w xof 1 mM at pH 7 and 208C 118 . Using leaky
vesicles, de Meis et al. have shown that ATP could
be synthesized in the absence of a Ca2q gradient,
provided that a mixture of Ca2q and ADP was added
w xto E-P 119 . These authors studied ATP synthesis as
a function of the Ca2q concentration under various
conditions that yielded other estimates of the lumenal
affinity for Ca2q. Of particular interest is that at pH 8
and 08C, half the maximal amount of ATP synthe-
sized was obtained with 10 mM Ca2q, instead of 300
mM at pH 8 and 308C or pH 7 and 08C. Although
these numbers should not be taken as absolute values
for Ca2q affinity, it is likely that alkaline pH and low
temperatures increase the lumenal affinity for Ca2q.
Occluded Ca2q in the Ca2q-bound phosphoenzyme
dissociates slowly toward the lumen, which suggests
a deocclusion step prior to Ca2q dissociation. This
would explain why, at pH 6 or 7 and 208C, it has not
been possible to measure a sequential dissociation of
2q w xthe two Ca ions 120,121 , and why there is as yet
no information available on the mechanism of Ca2q
dissociation toward the lumen under these conditions.
At pH 8 and low temperatures, however, Forge et al.
were able to determine that 45Ca2q dissociation from
the phosphoenzyme is impaired by 40Ca2q, as it is
w xfrom the non-phosphorylated ATPase 114 . There-
fore, on this side of the membrane too, lumenal
dissociation of the Ca2q ions is compatible with a
channel-like structure, as it also seems to be sequen-
tial.
Inesi has proposed that the transport sites are
w xorganized in a channel-like structure 47 which, as
mentioned above, would be formed by the putative
w xmembrane helices M4, M5, M6 and M8 43 . To
reach his original proposal, Inesi selectively placed a
40Ca2q on top of a 45Ca2q from the cytoplasmic side
as in Scheme 4, to determine whether their dissocia-
w xtion toward the lumen is sequential 47 . From obser-
vations of the internalization of the Ca2q ions after
phosphorylation, Inesi concluded that their dissocia-
tion toward the lumen is sequential and that the first
Ca2q bound to the ATPase is the first to be internal-
ized. As mentioned above, it has also been reported
twice that the two Ca2q ions are not distinguishable
w xon the lumenal side 120,121 . Thus, the question
whether the first Ca2q bound from the cytoplasm is
the first to be released in the lumen is still under
debate. In other words, it is still not clear whether
during transport the order of binding of the two Ca2q
to the cytoplasm-facing sites is retained during occlu-
sion and dissociation from the lumen-facing sites. A
strict preservation of this order would be a strong
indication that Ca2q crosses the ATPase through a
channel. This problem has been recently tackled in
our laboratory under conditions allowing measure-
ment of sequential dissociation toward the lumen
w x114 . It was found that during occlusion the two
Ca2q ions are randomized, so that although they bind
and dissociate sequentially, the first ion to bind can
w xbe the first or the second to dissociate 122 . Such
randomization suggests that during the occlusion step
the structure of the Ca2q sites loosens to allow the
two Ca2q ions to exchange positions. This is at odds
with the idea of a narrow channel in the phosphoen-
zyme. From the structural point of view, the channel
proposed by Inesi is still discussed in the literature
w x37,39,46,48–50 .
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4.5. ATPase cycle
4.5.1. ATP utilization as energy source
After binding Ca2q, the ATPase becomes phos-
phorylatable and ATPase activity requires Mg2q, the
physiological co-substrate, and micromolar ATP
w x123 . ATP binds to several species along the cat-
alytic cycle whether these species are saturated by
Ca2q or not. Binding is fast and has only been
directly measured at pH 7 and 58C for micromolar
concentrations. Under these conditions, the on and
off rate constants are, respectively, 4=106 My1 sy1
and 10 sy1 for Ca E and 7=106 My1 sy1 and 252
y1 w xs for E 124 . According to Jencks and coworkers,
after Ca2q and ATP binding, the Ca EATP ternary2
complex undergoes a rate-limiting conformational
 y1 .change 220 s at pH 7 and 258C which is followed
 y1.by rapid phosphoenzyme formation )1000 s
w xand concomitant ADP dissociation 112,125 , the
Mg2q ion remaining bound to the phosphoenzyme
w x126 . Therefore, ATP binding is generally not a
rate-limiting step except when ATP is in the micro-
molar range.
After covalent phosphorylation and ADP dissocia-
tion, the two Ca2q ions bound to the phosphoenzyme
are inaccessible from inside or outside the vesicles.
They are considered as transiently occluded in the
protein, in the form denoted by Ca E-P, in Scheme2
1. Ca E-P is the so-called ADP-sensitive phosphoen-2
zyme, as it reacts with ADP to synthesize ATP.
Ca E-P is intrinsically unstable and, when the lume-2
nal Ca2q concentration is low, Ca2q dissociates from
the phosphoenzyme which loses its sensitivity to
ADP. E-P, the Ca2q-deprived phosphoenzyme, is the
so-called ADP-insensitive phosphoenzyme. The inter-
conversion between the two phosphoenzymes de-
pends on the experimental conditions. In particular,
low temperatures, high KCl and high lumenal Ca2q
w xfavor the ADP-sensitive phosphoenzyme 127,128 .
Kanazawa has recently shown that a conformational
change occurs upon phosphorylation and conversion
w x 2qof Ca E-P into E-P 129 . After Ca dissociation in2
the vesicle lumen, E-P reacts with water and dephos-
phorylates leaving ATPase ready to start a new cycle
 .Scheme 1 .
A remarkable feature of both ADP-sensitive and
ADP-insensitive phosphoenzymes is the stability at
acidic pH of the covalent bond between the phos-
phate and the Asp351. Acid quenching of the phos-
phorylation reaction by 0.5 M HCl or 0.12 M PCA,
for instance, allows direct estimate of the amount of
radioactive 32P bound to the ATPase, i.e. total phos-
phoenzyme. This possibility, together with the ADP-
sensitivity which induces fast dephosphorylation of
Ca E-P, has allowed meticulous study of the phos-2
phorylation reaction and of the Ca E-PlE-P inter-2
conversion.
4.5.2. ATP as cycle modulator
In addition to ATP, Ca2q-ATPase catalyzes the
w xhydrolysis of ITP, GTP, CTP and UTP 130,131 .
This lack of specificity spreads to non-nucleotide
energy-rich compounds as acetylphosphate or p-
w xnitrophenylphosphate 132–134 . All these nucleotide
and non-nucleotide substrates phosphorylate the AT-
Pase and sustain Ca2q transport, but only ATP in-
creases the rate of turnover at high concentration
w x32,123 . As the site of micromolar affinity is the
catalytic site, there has been a great deal of discus-
sion as to whether the lower affinity site is the
catalytic or a regulatory site, especially because stud-
ies of ATP binding at equilibrium have revealed one
 w x.or two different sites for instance, see 32,135–137 .
ATP is known to accelerate Ca2q-binding from the
w x 2qcytoplasm 98,101,138–140 , Ca -release into the
w xSR lumen 128,141 , and dephosphorylation. In this
latter case, it has been shown that free ATP binds to
E-P and increases the rate of E-P hydrolysis, whereas
w xthe MgATP complex does not bind to E-P 142,143 .
In other words, ATP increases the rate of all steps
which start from a nucleotide-deprived species steps
.1, 3 and 4 in Scheme 1 , suggesting that it binds to
the nucleotide site, even on the phosphoenzyme, so
that during consecutive cycles, ATP enters the cycle
as soon as ADP has dissociated. Therefore it has been
proposed that enhancement of Ca2q-ATPase activity
occurs via the binding of ATP to the phosphoenzyme
w xat the catalytic site 142,144,145 .
4.5.3. Interaction between catalytic and transport
sites
Given that there is millimolar ATP in the cyto-
plasm, an understanding of how ATP modulates the
Ca2q-binding step will lead to a description of the
Ca2q-binding mechanism closer to the in vivo phe-
nomenon. In vitro experiments are often conducted
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starting from the Ca2q-deprived enzyme and adding
successively Ca2q and ATP, as described in Scheme
1. However, at pH 6 when the cycle turnover is 10
sy1, Ca2q binds with a rate constant of 1 sy1 in the
absence of ATP, which is much too slow to represent
a step belonging to the cycle. In contrast, when there
is a non-hydrolyzable ATP analogue, the Ca2q-bind-
y1 w xing rate becomes 15 s 146 . This illustrates the
interaction between the catalytic and transport sites.
ATP modulates both the kinetics of Ca2q binding
and its affinity at equilibrium and this modulation
depends on pH. As mentioned above, at pH 6 where
Ca2q binding is monophasic and slow, non-hydro-
lyzable ATP analogues such as ADP, AMPPCP and
AMPPNP accelerate Ca2q binding. At pH 7 and 8,
where Ca2q binding is biphasic, these nucleotides
induce fast, monophasic Ca2q binding with an appar-
ent dissociation constant of 10 mM. Therefore, the
slow phases observed when Ca2q binding starts from
protonated species as proposed in Scheme 2 are
abolished in the presence of nucleotides. ATP ana-
logues also modulate equilibrium Ca2q binding as
they increase Ca2q affinity at acidic pH but have no
w xeffect at alkaline pH 146 .
4.5.4. Re˝erse cycle and ATP synthesis
Ca2q-ATPase cycle is reversible and leads to ATP
synthesis, provided that intact vesicles previously
loaded with calcium are given Mg2q, ADP and P ini
2q w xthe absence of external Ca 8,9 . The absence of
Ca2q in the external medium is an absolute pre-
requisite for P phosphorylation, as is the presence ofi
Ca2q at the high-affinity transport sites for ATP
phosphorylation. As illustrated in Scheme 2, alkaline
pH favors Ca2q binding and therefore ATP phospho-
rylation, whereas acidic pH favors ATPase protona-
tion and therefore P phosphorylation.i
Assuming that the Ca2q-ATPase is a Ca2qrH q
antiporter, this Ca2qrH q exchange at the transport
sites is responsible for the switch in chemical reacti˝-
ity, i.e. phosphorylability either by ATP or by P .1
The reverse cycle can be summarized as follows.
First, the Ca2q-deprived ATPase is spontaneously
phosphorylated by P in the presence of Mg2q andi
2q w x  .absence of Ca 10,11 step 4 in Scheme 1 . In the
absence of lumenal Ca2q, i.e. when the vesicles are
empty, E-P is stable, whereas when the vesicles are
loaded with Ca2q, phosphoenzyme formation is fol-
lowed by lumenal Ca2q binding leading to Ca E-P2
w x  . 2q118 step 3 in Scheme 1 . Because of the Ca
load, the Ca2q-bound phosphoenzyme is stable, un-
less there is ADP in the medium. Once ADP has
bound to Ca E-P, the covalently bound phosphate is2
 .transferred to ADP step 2 in Scheme 1 . Dephospho-
rylation and Ca2q release in the external medium
follow, so that ATP synthesis is coupled to Ca2q
efflux and lasts as long as there is enough Ca2q in
the lumen, and enough P and ADP in the externali
medium.
Nevertheless, the Ca2q gradient is not mandatory
since purified ATPase or ATPase embedded in leaky
vesicles can also synthesize ATP, provided a mixture
of Ca2q and ADP is added to E-P, the phosphoen-
zyme which has previously been formed in the ab-
2q w xsence of Ca 147 . This mode of ATP synthesis
calls for at least two comments. Due to the reversibil-
ity of each step, the yield is limited to approximately
10%, except when the experimental conditions are
optimized for each step, and thus for a particular
w xexperimental protocol. Leaky vesicles 148 must be
used to allow access to the lumenal Ca2q sites from
the reaction medium. ADP and Ca2q should be added
simultaneously because both high- and low-affinity
Ca2q-binding sites compete for Ca2q. Ca2q binding
to the cytoplasmic sites pulls the cycle towards de-
phosphorylation whereas Ca2q binding to the lume-
nal sites leads to ATP synthesis. ATP is synthesized
because Ca2q binding to the lumenal sites is faster
than E-P dephosphorylation and because ADP binds
almost instantaneously to Ca E-P.2
4.5.5. The di˝alent cation at the catalytic site
Mg2q is the physiological co-substrate for both
ATP and P phosphorylation reactions. However,i
MgATP is not the only possible substrate for phos-
phorylati6n in the forward direction. CoATP, MnATP,
CaATP, ZnATP, LaATP have also been shown to
induce ATPase activity with higher or lower turnover
rates, as compared with the MgATP-induced turnover
w x95,116,149–151 . In the reverse direction, phospho-
rylation by P has also been proved possible in thei
absence of Mg2q, using Co2q, Mn2q, Cd2q, Ni2q or
2q w x 2qeven Ca 143 . With Ca , phosphorylation by Pi
can only be transient as Ca2q binding to the high-af-
finity transport sites dephosphorylates E-P.
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4.5.6. P phosphorylation mechanismi
 .P phosphorylation step 4 in Scheme 1 was firsti
w xdescribed in 1973 at equilibrium 10,11 . There have
been numerous studies on the different factors influ-
encing this reaction, such as temperature, organic
solvents, pH, KCl and ATP see for instance
w x.119,152–156 .
As already pointed out, P phosphorylation re-i
quires the presence of a divalent cation as co-sub-
strate and also high-affinity transport sites deprived
of Ca2q. It is favored by acidic pH, as shown by the
fact that maximum phosphorylation is achieved at pH
w x6 11 . This suggests that the transport sites can be
occupied by Hq and that the EH species described3
in Scheme 2 is actually the species phosphorylatable
w xby P 94 . From measurements of E-P levels as ai
function of free P and free Mg2q, Suko and cowork-i
ers have proposed that P and Mg2q bind indepen-i
dently, with dissociation constants in the 1–10 mM
range, as described in Scheme 5, and that the phos-
phorylation reaction occurs only when the ternary
w xcomplex EP Mg has been formed 153,154 . There-i
fore, the EP MglE-PMg step describes the truei
phosphorylation step and was found to have an equi-
librium constant of 1.6 at pH 7 k rk in Scheme5 y5
.5 , corresponding to partial phosphorylation
w x153,154 . The same random scheme has been used to
describe P phosphorylation at pH 6. The individuali
dissociation constants were in the millimolar range,
as at pH 7, but the equilibrium constant of the
phosphorylation step was at least 10, therefore lead-
w xing to full phosphorylation 157 .
One water molecule is necessary to hydrolyze the
covalent bond in E-P. Phosphorylation with 18O-
labeled P in a buffer containing unlabeled wateri
 16 . 18 16H O results in an Ol O exchange on P ,2 i
which originates from the incorporation of an oxygen
atom of water into P due to hydrolysis of E-P. Thei
distribution of the different 18O-P species as a func-i
tion of time can be used to calculate the rate constant
 .for E-P hydrolysis k in Scheme 5 and shows thaty5
Scheme 5.
the phosphorylation reaction has occurred, even un-
der such conditions where there is no detectable
phosphoenzyme. This technique has shown that the
more alkaline the pH, the faster the dephosphoryla-
tion rate, explaining the absence of measurable E-P
levels at alkaline pH, as well as the full phosphoryla-
w xtion obtained at pH 6 155 . The same explanation
was given for the effect of KCl, which is known to
decrease the level of phosphoenzyme by increasing
the rate of dephosphorylation.
Among the effectors of P phosphorylation, or-i
ganic solvents such as Me SO were proved to favor2
phosphoenzyme formation, i.e. the concentrations of
P or Mg2q needed to phosphorylate are decreasedi
w x10- to 100-fold 119 . This has been attributed to an
 . w xincrease in P affinity K or K in Scheme 5 119 ,i 2 3
or to an increase in k , the phosphorylation rate,5
together with a decrease in k , the dephosphoryla-y5
w xtion rate 156 . Me SO can be added up to 40% and2
allows full phosphorylation even at alkaline pH and
at low temperatures, two conditions under which
there is no detectable E-P in water. Me SO is there-2
fore a usefiil tool when fiill P phosphorylation isi
needed, and its effect on phosphorylation seems to be
a general effect on P-type ATPases.
P phosphorylation induces a conformationali
change which is reflected by an intrinsic fluorescence
w xincrease 157 . TNP-ATP, a fluorescent ATP ana-
logue which binds to ATPase without inducing the
cycle, has been used to probe the hydrophobicity of
the catalytic site. The fluorescence of bound TNP-
ATP increases upon P phosphorylation and this hasi
been related to an increase in the hydrophobicity of
w xthe catalytic site due to its dehydration 158 . Given
that the catalytic site is more hydrophobic than the
buffer and that addition of Me SO increases the2
hydrophobicity of the buffer, it has been proposed
that Me SO favors P binding to the phosphorylation2 i
w xsite 159 . This is at variance with the hypothesis that
Me SO directly affects the phosphorylation reaction2
w x156,160 .
The mechanism by which Me SO stimulates P2 i
phosphorylation of all P-type ATPases is an interest-
ing question per se. P affinity is difficult to measurei
directly, because the 1–100 mM range is required
and there is no specific spectroscopic response upon
addition of P to E. The effect of Me SO on Pi 2 i
affinity was tested indirectly, via measurements of
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Ca2q binding at the high-affinity transport sites. At
equilibrium, cytoplasmic Ca2q binding was not af-
fected by Me SO, except in the presence of P and2 i
Mg2q and under conditions where phosphorylation
w xoccurs 160 . Therefore, there were no detectable
effects of Me SO on Ca2q, Mg2q or P affinities. It2 i
is worth recalling here that Me SO inhibits ATP2
2q synthesis by inhibiting lumenal Ca binding step 3
. w xin Scheme 1 119 and markedly slows down the
kinetics of the intrinsic fluorescence change upon
2q  .Ca binding and dissociation step 1 in Scheme 1
w x143 . It was recently shown that Me SO greatly2
retards phosphoryl transfer during ATP phosphoryla-
w xtion of ATPase 161 . Consequently, Me SO is more2
likely to affect the enzyme directly, during conforma-
tional changes and P phosphorylation reaction, ratheri
than indirectly via the balance between the medium
and catalytic site hydrophobicity.
5. Two or four calcium sites? E -E model?2 1
The results reviewed above have been generally
interpreted on the basis of a minimum model, the
so-called E -E model, proposed by Makinose in2 1
w x1973 162 and strongly substantiated by de Meis and
w xcoworkers 5,163 . This model, which has been such
a fruitful working hypothesis, foresees two main
conformations for the ATPase during the overall
transport reaction. There are only two Ca2q sites
which either have high affinity and are accessible
from the cytoplasmic side when the ATPase is in the
E conformation or have low affinity and are accessi-1
ble from the lumen when the ATPase is in the E2
conformation. E captures Ca2q in the cytoplasm, is1
then phosphorylated by ATP to form Ca E -P, the2 1
Ca2q-bound phosphoenzyme, which undergoes a con-
formational change to E -P. The two bound Ca2q are2
released in the lumen after reorientation of the Ca2q
sites.
Two questions concerning this model arise from
recent publications. Are two Ca2q sites sufficient to
allow the Ca2q ions to cross the SR membrane, given
that no conformational change of large amplitude has
w xbeen detected during the cycle 164–166 ? Does the
E -E model still hold given the characteristics of the2 1
transport cycle known today and the multiple changes
in conformation detected throughout the cycle? For
instance, the intrinsic fluorescence variations indicate
multiple conformational changes upon Ca2q, Mg2q,
and ATP binding and P phosphorylationi
w x137,157,167,168 .
Recently, two groups have reported results which
were interpreted on the basis of the co-existence of
2q w xfour Ca -binding sites 71,72,169–171 . According
to Meszaros and Bak, it is possible to occlude bound´ ´
Ca2q and bind cytoplasmic Ca2q simultaneously,
suggesting the co-existence of lumenal low-affinity
and cytoplasmic high-affinity Ca2q sites on the same
w xATPase molecule 71,169 . According to Jencks and
coworkers, lumenal Ca2q impairs full phosphoryla-
tion from Pi suggesting that two low-affinity lumenal
sites co-exist with two high-affinity cytoplasmic sites
w xon the non-phosphorylated enzyme 72 . Jencks et al.
propose that the binding of Ca2q renders the ATPase
phosphorylatable by ATP, but the occupancy of the
high-affinity sites does not allow us to determine
what the occupancy of the low-affinity sites might be.
The two pairs of sites are considered as independent
and only phosphorylation by ATP changes the state
of the Ca2q sites: it moves the two Ca2q from the
cytoplasm-facing sites to the lumen-facing sites and
w xcloses the access from the cytoplasm 170 . At this
stage the phosphoenzyme is ADP-sensitive and Ca2q
dissociation toward the lumen is the rate-limiting step
2q w xin the Ca transport cycle 171 .
The co-existence of four Ca2q-binding sites has
not yet been substantiated by other groups. This
would require design of experimental conditions al-
lowing accumulation of this hypothetical species,
which is thought to bind four Ca2q ions at steady-
state, and then measurement of Ca2q binding.
5.1. Current assumptions about the transport mecha-
nism across the membrane
The fact that Ca2q dissociation toward the cyto-
plasm and Ca2q dissociation toward the lumen are
both sequential suggests that the Ca2q sites are orga-
nized in a channel-like structure. Nevertheless, by
following each individual Ca2q ion during its trans-
port from the cytoplasm toward the lumen, as well as
from the lumen toward the cytoplasm, Canet et al.
found that the two ions are mixed during their occlu-
w xsion in the membrane 122 . This randomization re-
quires more than two sites because the ions need to
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Scheme 6.
exchange positions. This is difficult to reconcile with
the structure of a narrow channel in the phospho-
erzyme and is also more in agreement with the
two-pairs-of-sites assumption.
Since the proposal of models for the structure of
the Ca2q-ATPase, the possibility that the two Ca2q
ions can be superimposed in a channel formed by the
transmembrane segments M4, M5, M6 and M8 has
w xbeen discussed in the literature 37,46,48–50 . As-
suming that there are four Ca2q-binding sites, then
during phosphorylation and dephosphorylation there
must be transfer of the Ca2q ions from one pair of
sites to the other, during which the Ca2q ions are
 .randomized Scheme 6A . Recently, Martonosi pro-
posed a structural model accounting for four possible
sites with two channels, each one being the way for
one Ca2q ion to cross the membrane. One channel
would be the above described channel and the other
one would be formed by the transmembrane seg-
w xments M2, M3, M4 and M5 39 . Because in this
model each Ca2q ion crosses the membrane in its
own channel, it does not allow the observed random-
w xization 122 . To be correct, this model should in-
clude, at least during phosphorylation and dephos-
phorylation, a different arrangement of the six helices
mentioned above, for instance an arrangement in a
tubular hexagonal structure allowing the Ca2q ions to
 .mix Scheme 6B . Note that the representation of the
two Ca2q ions as superimposed represents one possi-
ble structure - the simplest - in interpretation of the
sequential dissociation. The only requirement derived
from experiment is that the Ca2q sites are not inde-
pendent.
As the two Ca2q ions are thought to be random-
ized during their translocation, the transport cycle
must comprise a major structural change involving
the Ca2q sites. Starting from an ordered state for the
2q Ca ions, the chemical reaction phosphorylation or
.dephosphorylation must lead to another ordered state
for the Ca2q ions through a transient state where the
Ca2q coordinations become loose and allow random-
ization. Because phosphorylation and dephosphoryla-
tion reactions are very rapid, this transient state may
not have been seen in structural studies.
In summary, it is worth recalling that Ca2q-ATPase
offers many advantages, as it is easy to prepare,
stable, oriented in membrane vesicles, reversible, and
has been extensively studied since 1961. More struc-
tural information is now needed to confirm the possi-
bility of four sites across the membrane thickness.
Provided that both ftmctional and structural informa-
tion is gathered, understanding of the mechanism by
which Ca2q crosses the ATPase should increase,
thereby casting light on the whole P-type ATPase
family.
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